The Fetal Ultrasound Center offers pregnant women a continuous glucose monitoring system – Dexcom ONE+ with installation.
The Fetal Ultrasound Centre offers pregnant women a comprehensive Dexcom ONE+ continuous glucose monitoring service that continuously monitors blood glucose levels in real time, 24 hours a day.
Dexcom ONE+ Advantages and Features
Dexcom ONE+ is a simple, easy-to-apply sensor combined with a convenient all-in-one mobile app. No daily finger pricks or glucometer measurements are required.
Dexcom ONE+ is reliable and accurate, and clinical studies have shown that it:
- helps lower HbA1c (glycated haemoglobin) levels;
- increases the time spent within the target glucose range;
- is associated with better neonatal outcomes due to improved maternal glucose control.
Who is Dexcom ONE+ for?
-
For pregnant women with type 1 or type 2 diabetes
Benefits of continuous glucose monitoring in pregnant women with type 1 and type 2 diabetes:
- better glucose control: fewer high blood sugar levels and fluctuations;
- more precise insulin therapy: allows for faster and safer adjustments of insulin doses;
- lower risk of complications: protects mother and fetus from the dangers of blood sugar fluctuations;
- better sleep and nighttime control: alerts help prevent nocturnal hypoglycemia;
- greater confidence and quality of life: less anxiety and more control over your health.
-
For women with gestational diabetes
Benefits of Continuous Glucose Monitoring for Women with Gestational Diabetes:
- better glucose control: fewer high blood sugar episodes and smaller fluctuations;
- more effective insulin therapy: faster treatment optimisation and safer diabetes management;
- fewer complications: reduced risk of macrosomia (large babies) and maternal health issues;
- less stress: the system provides reassurance and peace of mind;
- improved lifestyle management: data allows for personalised nutrition and exercise recommendations.
-
For women who want to monitor their blood sugar levels during pregnancy to prevent excessive weight gain, gestational diabetes, and health problems in the fetus.
Continuous glucose monitoring can help detect and prevent gestational diabetes at an early stage:
- identifies early glucose abnormalities before diagnosis;
- helps recognise women at high risk;
- allows individualised dietary and physical activity adjustments;
- provides early warnings of metabolic changes;
- supports evidence-based prevention from the beginning of pregnancy.
Clinically Proven Results During Pregnancy
Using Dexcom ONE+ has been shown to:
- reduce the incidence of large-for-gestational-age infants (>4500 g);
- decrease the need for neonatal intensive care;
- reduce excessive maternal weight gain during pregnancy;
- lower the risk of pregnancy-induced hypertension;
- reduce the occurrence of neonatal hypoglycemia.
Device Use
The Dexcom ONE+ glucose monitor is a small device applied to the abdomen or upper arm.
- measures glucose levels in the interstitial (under-the-skin) fluid;
- worn for up to 10 days;
- water-resistant – suitable for showering and swimming;
- displays glucose data in real time on your smartphone;
- sends alerts when glucose levels become too high or too low.
Service at the Fetal Ultrasound Centre
A midwife at the Fetal Ultrasound Centre will provide a comprehensive introduction to the glucose monitor, assist with the initial installation, and help set up the mobile application.
If elevated glucose levels are detected, a glucose tolerance test can be performed at the Fetal Ultrasound Centre to diagnose gestational diabetes.
